Lupin and Unichem are liable to pay 53.9 million Euros in fines after a court in Europe upheld a 2014 order holding the Indian drug makers and other companies accountable for restricting the entry of generic hypertension drug Perindropil.
A total fine of 315 million Euros have been upheld on six companies. Lupin was fined 40 million Euros, and Unichem and its subsidiary Niche Generics were fined 13.9 million Euros by the European Commission in 2014. In a stock exchange notification on Wednesday, Lupin said the General Court has upheld European Commission decision to impose the fine. "Lupin will study the